Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January - February - March - April -
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
| 2002 -
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2002 - 20 products
IP
CI
Micardis Plus 80/12,5 mg
-
T
28 Tablet(s)
14.57
32.20
10 %
Tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Micardis Plus 80/12,5 mg
-
T
98 Tablet(s)
50.59
71.15
10 %
Tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Micardis Plus 80/25 mg
28 Tablet(s)
14.85
32.50
10 %
Tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Micardis Plus 80/25 mg
98 Tablet(s)
51.58
72.20
10 %
Tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
L
IP
V/S
HBVAXPRO 10
Fertigspritze(n) à 1 ml
25.23
43.85
10 %
Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/ml
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
V/S
HBVAXPRO 10
10 1 Fertigspritze(n) à 1 ml
252.30
290.80
10 %
Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/ml
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
SonoVue 8 µL/mL
Flasche(n)
78.01
101.25
10 %
polvere e solvente per dispersione iniettabile: Sulfuris Hexafluoridum 225 µg
Bracco Suisse SA
B / SL
FB
G
CI
H
Pinikehl D5
10 ampoule(s)
PR
PR
k.A.
Injection solution: Fomes Pinicola Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Pinikehl D5
50 ampoule(s)
PR
PR
k.A.
Injection solution: Fomes Pinicola Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
IP
V/S
HBVAXPRO 10
Durchstechflasche(n) à 1 ml
PR
PR
k.A.
Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/ml
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
CI
Ph
Chinamed
100 ml
PR
PR
k.A.
Emulsion: 3 Active Agents
DR. BÄHLER DROPA AG
D
FB
G
IP
CI
Ph
Chinamed
250 ml
PR
PR
k.A.
Emulsion: 3 Active Agents
DR. BÄHLER DROPA AG
D
FB
G
IP
CI
Belara
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belara
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belara
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Evit 800
50 Capsule(s)
PR
PR
k.A.
Capsules: Rrr-Alpha-Tocopherolum 536.8 mg
Doetsch Grether AG
D
FB
G
IP
CI
Evit 800
100 Capsule(s)
PR
PR
k.A.
Capsules: Rrr-Alpha-Tocopherolum 536.8 mg
Doetsch Grether AG
D
FB
G
CI
H
Cefavora
50 ml
PR
PR
k.A.
Drops: 2 Active Agents
steinberg pharma ag
D
FB
G
CI
H
Cefavora
100 ml
PR
PR
k.A.
Drops: 2 Active Agents
steinberg pharma ag
D
FB
G
IP
V/S
HBVAXPRO 5
ampoule(s)
22.42
42.10
k.A.
Injection suspension: Hepatitidis b Virus Antigenum Adnr 5 µg
Sanofi Pasteur MSD AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
